perylene has been researched along with Cancer of Pituitary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, SS; Cole, CD; Couldwell, WT; Liu, JK; Schmidt, MH; Sheng, X; Weiss, MH | 1 |
| Chen, ZH; Couldwell, WT; Gopalakrishna, R; Hamilton, HB; Hinton, DR; Law, RE; Su, YZ; Weiss, MH | 1 |
| Cerman, J; Mareková, M; Vávrová, J; Vokurková, D | 1 |
3 other study(ies) available for perylene and Cancer of Pituitary
| Article | Year |
|---|---|
Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model.
Topics: Animals; Anthracenes; Apoptosis; In Situ Nick-End Labeling; Perylene; Photochemotherapy; Pituitary Neoplasms; Radiation-Sensitizing Agents; Rats; Rats, Wistar | 2008 |
Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application.
Topics: Adenoma; Animals; Anthracenes; Apoptosis; Cell Division; Perylene; Pituitary Neoplasms; Protein Kinase C; Rats; Tumor Cells, Cultured | 1996 |
Light-induced photoactivation of hypericin inhibits cellular growth in pituitary adenoma cell line AtT20/D16v-F2 (hypericin inhibits cellular growth of AtT20/D16v-F2).
Topics: Adenoma; Animals; Anthracenes; Apoptosis; Cell Cycle; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Radiation; HL-60 Cells; Humans; Light; Mice; Perylene; Photosensitizing Agents; Pituitary Neoplasms; Protein Kinase C; Tumor Cells, Cultured | 2001 |